Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs iShares MSCI Taiwan ETF (EWT) Price & Performance

AbCellera Biologics IncTrade
iShares MSCI Taiwan ETFTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs iShares MSCI Taiwan ETF — how do they compare? AbCellera Biologics Inc trades at $9.3 (market cap $2.99B), while iShares MSCI Taiwan ETF trades at $106.14. Which is the better fit depends on your goals.

ABCLEWT
Market Cap
$2.99B
Sector
HealthBroad Market / Factor
52-Week High
$9.76$111.53
52-Week Low
$2.78$58.05
Enterprise Value
$2.58B

Returns comparison

Trailing returns across standard periods

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About iShares MSCI Taiwan ETF

EWT tracks the MSCI Taiwan 25/50 Index, providing targeted exposure to large and mid-cap companies in Taiwan. It is heavily concentrated in the information technology sector, serving as a liquid instrument for investors seeking a single-country view of Taiwan's export-oriented and tech-driven economy.

Read more on EWT